BioCentury
ARTICLE | Clinical News

hc2 High-Risk human papillomavirus regulatory update

December 8, 2003 8:00 AM UTC

DIGE received European CE Mark approval for its patient screening tests. The CE Mark means the tests comply with European regulatory requirements and allows DIGE to continue selling the HPV, chlamydia...